Digital Health · 2022 · 27 citations · 20 references
MedicineOncologyClinical Data ManagementMedical OncologyPrecision OncologyClinical Trial Data CollectionClinical Trial DesignClinical Trial EthicsClinical TrialsClinical Trials In OncologyStudy DesignBurdenClinical Trial Data IntegrationDecentralized Clinical TrialsDecentralized Trial Data CollectionEnrollmentLogisticsPatient Burden Assessment
As a result of the unprecedented challenges imposed by the COVID-19 pandemic on enrollment to cancer clinical trials, there has been an urgency to identify and incorporate new solutions to mitigate these difficulties. The concept of decentralized or hybrid clinical trials has rapidly gained currency, given that it aims to reduce patient burden, increase patient enrollment and retention, and preserve quality of life, while also increasing the efficiency of trial logistics. Therefore, the clinical trial environment is moving toward remote collection and assessment of data, transitioning from the classic site-centric model to one that is more patient-centric.
20
Participation in Cancer Clinical Trials
Vivek H. Murthy, Harlan M. Krumholz, Cary P. Gross · JAMA · 2004 · 2.1K citations
Patient Income Level and Cancer Clinical Trial Participation
Joseph M. Unger, Dawn L. Hershman, Kathy S. Albain et al. · Journal of Clinical Oncology · 2013 · 287 citations
David Waterhouse, R. Donald Harvey, Patricia A. Hurley et al. · JCO Oncology Practice · 2020 · 201 citations
Medicine, Oncology, Cancer Control +15